Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat

M. E. De Jonge; A. D.R. Huitema; J. H. Beijnen; J. H.M. Schellens; S. Rodenhuis

Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat

Translated title of the contribution: Successful rechallenge with cromoglycate prophylaxis. Hypersensitivity reaction in chemotherapy

M. E. De Jonge
, A. D.R. Huitema
, J. H. Beijnen
, J. H.M. Schellens
, S. Rodenhuis

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.

Translated title of the contribution	Successful rechallenge with cromoglycate prophylaxis. Hypersensitivity reaction in chemotherapy
Original language	Dutch
Pages (from-to)	874-878
Number of pages	5
Journal	Pharmaceutisch Weekblad
Volume	138
Issue number	25
Publication status	Published - 20 Jun 2003
Externally published	Yes

Cite this

@article{56dfd47647824be6962a815bf7150db5,

title = "Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat",

abstract = "Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.",

keywords = "Antineoplastic agents, Case report, Cromoglycic acid, Hypersensitivity",

author = "\{De Jonge\}, \{M. E.\} and Huitema, \{A. D.R.\} and Beijnen, \{J. H.\} and Schellens, \{J. H.M.\} and S. Rodenhuis",

year = "2003",

month = jun,

day = "20",

language = "Nederlands",

volume = "138",

pages = "874--878",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "25",

}

TY - JOUR

T1 - Overevoeligheidsreactie bij chemotherapie

T2 - Succesvolle 'rechallenge' met cromoglicaat

AU - De Jonge, M. E.

AU - Huitema, A. D.R.

AU - Beijnen, J. H.

AU - Schellens, J. H.M.

AU - Rodenhuis, S.

PY - 2003/6/20

Y1 - 2003/6/20

N2 - Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.

AB - Hypersensitivity reactions (HSRs) are not uncommon in chemotherapy. In some situations antihistaminics and corticosteroids may be used in the prevention of HSRs. In this case report, a breast cancer patient with a severe HSR on high dose cyclophosphamide, thiotepa and carboplatin (tCTC) is described, who was able to continue tCTC therapy successfully after use of prophylactic oral cromoglycate. It was concluded that cromoglycate may be useful in the prophylaxis of chemotherapy-induced HSRs and should be further studied in this setting.

KW - Antineoplastic agents

KW - Case report

KW - Cromoglycic acid

KW - Hypersensitivity

UR - https://www.scopus.com/pages/publications/0038611020

M3 - Artikel

AN - SCOPUS:0038611020

SN - 0031-6911

VL - 138

SP - 874

EP - 878

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 25

ER -

Overevoeligheidsreactie bij chemotherapie: Succesvolle 'rechallenge' met cromoglicaat

Abstract

Fingerprint

Cite this